haha 777 agent
haha 777 agent
This pricey midcoast property is free for someone to farmMomentus Inc. Announces Reverse Stock Split
HUNTSVILLE, Ala. (AP) — Paul Zilinskas put up 32 points as IU Indianapolis beat Alabama A&M 88-83 on Monday. Zilinskas shot 11 for 20 (5 for 10 from 3-point range) and 5 of 5 from the free-throw line for the Jaguars (3-5). Jarvis Walker scored 13 points while going 3 of 9 from the floor, including 2 for 5 from 3-point range, and 5 for 7 from the line. Timaris Brown and Sean Craight both added 11 points. Darius Ford led the Bulldogs (4-4) in scoring, finishing with 20 points, six rebounds, seven assists and two steals. Anthony Bryant added 17 points for Alabama A&M. Chad Moodie also had 16 points and three blocks. The Associated Press created this story using technology provided by and data from .Gophers football continues to restock offensive linemen for 2025None
Russian President Vladimir Putin said Friday that Moscow would carry out more tests of the hypersonic Oreshnik ballistic missile in "combat conditions," a day after firing one on Ukraine. "We will continue these tests, including in combat conditions, depending on the situation and character of the security threats posted to Russia," Putin said in a televised meeting with military chiefs. Russia fired the new-generation missile at the Ukrainian city of Dnipro early on Thursday in a major escalation of the weaponry being deployed in the nearly three-year conflict. The Kremlin boss also ordered the missile, which flies at speeds of Mach 10 -- 10 times the speed of sound -- to be put into serial production (mass production). Russia is developing similar advanced systems, he added. "We need to begin serial production. The decision... has in effect been taken," Putin said, praising the "particular strength of this weapon and its power. "The weapon system that was tested yesterday is another faithful guarantee of Russia's territorial integrity and sovereignty," he added. Putin claimed no other countries in the world had such missile technology. While he conceded other states would soon develop them, he said: "That will be tomorrow, after a year or two. But we have this system now. That's important." His choreographed meeting with the defence minister and those in charge of developing the missile came at the end of a week that has seen the Ukraine conflict escalate rapidly. Putin said the firing of the Oreshnik missile was a direct response to Kyiv's forces using US- and UK-supplied missiles on Russian territory for the first time. In an address to the nation on Thursday, Putin said Russia reserved the right to fire missiles at military facilities in countries whose weapons are being used by Ukraine -- specifically the United States and Britain.SAN DIEGO , Dec. 23, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, announced today the relocation of the Company's headquarters from San Diego, California to Cary, North Carolina , effective January 1, 2025 . A majority of Heron's Management Team and corporate employees work from the Cary office, which is near the Research Triangle Park ("RTP"), one of the most prominent high-tech research and development parks in the United States . The growing biotech community in Cary and its surrounding areas provides ample space for growth and expansion. "We are excited to move our headquarters to Cary, North Carolina , which represents a significant milestone in Heron's journey," said Craig Collard , Chief Executive Officer of Heron. "This move will not only strengthen our ability to support our employees by centralizing our operations and resources, but also positions us in an excellent location from which we can continue making strategic partnerships as we growing our existing portfolio focused on improving the lives of patients in the acute and oncology care settings. This is an exciting chapter for Heron, and we look forward to the continued success and partnerships that lie ahead." The new address for Heron's corporate headquarters is 100 Regency Forest Drive, Suite 300, Cary, NC 27518. About Heron Therapeutics, Inc. Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com . Forward-looking Statements This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. Therefore, you should not place undue reliance on forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors." Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law. Investor Relations and Media Contact: Ira Duarte Executive Vice President, Chief Financial Officer Heron Therapeutics, Inc. iduarte@herontx.com 858-251-4400 View original content to download multimedia: https://www.prnewswire.com/news-releases/heron-therapeutics-announces-corporate-headquarters-relocation-to-cary-north-carolina-302338528.html SOURCE Heron Therapeutics, Inc.
